IMNP - Immune Pharmaceuticals Inc.

Industry: Drug Manufacturers - Major Sector: Healthcare | Exchange: NASDAQ

Buy Candidate
Thu 21'st Sep 2017

PERIOD 2017-06-22 - 2017-09-21
CHANGE 4.67%
PRICE $1.12
VOLUME
Buy
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

BOLLINGER
Sell
Request Prediction
0.00%
Predict

Immune Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Thu 21'st Sep 2017

Buy candidate since 2017-09-20 Gain 4.67%

Immune Pharmaceuticals Inc. gained 4.67% in the last trading day, rising from $1.07 to $1.12 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days and is down by -5.19% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 428 216 more shares were traded than the day before. In total, 742 683 shares bought and sold for approximately $831 805.

Trend

Immune Pharmaceuticals Inc. lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -62.61% during the next 3 months and, with 90% probability hold a price between $0.15 and $0.54 at the end of this period.

Signals

A buy signal was issued from a pivot bottom point on Tuesday September 19, 2017, which indicates further gains until a new top pivot has been found. Immune Pharmaceuticals Inc. has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. Immune Pharmaceuticals Inc. holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.29. On a fall, the stock will find some support from the short-term average at $1.09. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Relative Strength Index (RSI)

RSI14 is 43 and the stock is currently not being overbought or oversold

Support & Resistance

Immune Pharmaceuticals Inc. finds support from accumulated volume at $1.11. On the upside the stock meets some resistance just above today's level from accumulated volume at $1.16, $1.20 and $1.29.

The stock is about to test the resistance from accumulated volume at $1.16 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $1.11 Price: $1.12 Resistance: $1.16
S: $1.11 Price: $1.12 R: $1.16

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 12.15%. For the last week, the stock has had a daily average volatility of 6.23%.

Our recommended stoploss: $1.05 (-6.57%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 2 days ago.)

Overall risk:

Very Low Low Medium High Very High

Overall risk:

           

Evaluation

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.

Buy Candidate

Trade IMNP CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service. Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Help StockInvest improve by answering this short survey clicking HERE.

Build Your Watchlist

Add IMNP My Watchlist

Recommended
books of the week

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Sign up to get FREE access to awesome features

Auto-portfolios that gain up to 30%

Request predictions from other users

Watchlist builder with notifications

News updates from 100+ financial publications

START FREE 5-DAY TRIAL
START FREE 5-DAY TRIAL